Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
14,005 | Dovepress* | 11,245+ | 1,952 | 13,197 | |
PubMed Central* | 2,760 | 490 | 3,250 | ||
Totals | 14,005 | 2,442 | 16,447 | ||
*Since 31 March 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar